Prolactinoma overview: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Prolactinoma}} | {{Prolactinoma}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
A '''prolactinoma''' is a [[benign]] [[tumor]] ([[adenoma]]) of the '''[[pituitary gland]]''' that produces a [[hormone]] called [[prolactin]]. It is the most common type of [[pituitary tumor]]. Symptoms of prolactinoma are caused by too much prolactin in the blood ([[hyperprolactinemia]]) or by pressure of the tumor on surrounding tissues. | A '''prolactinoma''' is a [[benign]] [[tumor]] ([[adenoma]]) of the '''[[pituitary gland]]''' that produces a [[hormone]] called [[prolactin]]. It is the most common type of [[pituitary tumor]]. Symptoms of prolactinoma are caused by too much prolactin in the blood ([[hyperprolactinemia]]) or by pressure of the tumor on surrounding tissues. | ||
Prolactin stimulates the [[breast]] to produce milk during [[pregnancy]]. After delivery of the baby, a mother's prolactin levels fall unless she breast feeds her infant. Each time the baby nurses, prolactin levels rise to maintain milk production. | Prolactin stimulates the [[breast]] to produce milk during [[pregnancy]]. After delivery of the baby, a mother's prolactin levels fall unless she breast feeds her infant. Each time the baby nurses, prolactin levels rise to maintain milk production. | ||
==Historical Perspective== | ==Historical Perspective== | ||
==Classification== | ==Classification== | ||
Based on size, a prolactinoma can be classified as a ''microprolactinoma'' (<10 mm diameter) or ''macroprolactinoma'' (>10 mm diameter). | Based on size, a prolactinoma can be classified as a ''microprolactinoma'' (<10 mm diameter) or ''macroprolactinoma'' (>10 mm diameter). | ||
==Pathophysiology== | ==Pathophysiology== | ||
==Prolactinoma and Pregnancy== | ==Prolactinoma and Pregnancy== | ||
Women with prolactin-secreting tumors may experience further pituitary enlargement and must be closely monitored during pregnancy. However, damage to the pituitary or eye nerves occurs in less than one percent of pregnant women with [[prolactinoma]]. In women with large tumors, the risk of damage to the pituitary or eye nerves is greater, and some doctors consider it as high as 25%. | Women with prolactin-secreting tumors may experience further pituitary enlargement and must be closely monitored during pregnancy. However, damage to the pituitary or eye nerves occurs in less than one percent of pregnant women with [[prolactinoma]]. In women with large tumors, the risk of damage to the pituitary or eye nerves is greater, and some doctors consider it as high as 25%. | ||
==Causes== | ==Causes== | ||
It has been shown that stress can significantly raise [[prolactin]] levels which should make stress a diagnostic differential though it usually is not considered such. Most [[pituitary]] tumors are sporadic--they are not genetically passed from parents to offspring. | It has been shown that stress can significantly raise [[prolactin]] levels which should make stress a diagnostic differential though it usually is not considered such. Most [[pituitary]] tumors are sporadic--they are not genetically passed from parents to offspring. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
[[Autopsy]] studies indicate that 6-25% of the U. S. population have small pituitary tumors. Forty percent of these pituitary tumors produce prolactin, but most are not considered clinically significant. Clinically significant pituitary tumors affect the health of approximately 14 out of 100,000 people in United States. | [[Autopsy]] studies indicate that 6-25% of the U. S. population have small pituitary tumors. Forty percent of these pituitary tumors produce prolactin, but most are not considered clinically significant. Clinically significant pituitary tumors affect the health of approximately 14 out of 100,000 people in United States. | ||
==Differentiating prolactinoma from other diseases== | ==Differentiating prolactinoma from other diseases== | ||
==Natural History, Complications and Prognosis== | ==Natural History, Complications and Prognosis== | ||
==History and Symptoms== | ==History and Symptoms== | ||
==Physical Examination== | ==Physical Examination== | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
==CT Scan== | ==CT Scan== | ||
==MRI== | ==MRI== | ||
==Medical Therapy== | ==Medical Therapy== | ||
==Surgery== | ==Surgery== | ||
Revision as of 14:27, 3 September 2015
|
Prolactinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Prolactinoma overview On the Web |
|
American Roentgen Ray Society Images of Prolactinoma overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
A prolactinoma is a benign tumor (adenoma) of the pituitary gland that produces a hormone called prolactin. It is the most common type of pituitary tumor. Symptoms of prolactinoma are caused by too much prolactin in the blood (hyperprolactinemia) or by pressure of the tumor on surrounding tissues. Prolactin stimulates the breast to produce milk during pregnancy. After delivery of the baby, a mother's prolactin levels fall unless she breast feeds her infant. Each time the baby nurses, prolactin levels rise to maintain milk production.
Historical Perspective
Classification
Based on size, a prolactinoma can be classified as a microprolactinoma (<10 mm diameter) or macroprolactinoma (>10 mm diameter).
Pathophysiology
Prolactinoma and Pregnancy
Women with prolactin-secreting tumors may experience further pituitary enlargement and must be closely monitored during pregnancy. However, damage to the pituitary or eye nerves occurs in less than one percent of pregnant women with prolactinoma. In women with large tumors, the risk of damage to the pituitary or eye nerves is greater, and some doctors consider it as high as 25%.
Causes
It has been shown that stress can significantly raise prolactin levels which should make stress a diagnostic differential though it usually is not considered such. Most pituitary tumors are sporadic--they are not genetically passed from parents to offspring.
Epidemiology and Demographics
Autopsy studies indicate that 6-25% of the U. S. population have small pituitary tumors. Forty percent of these pituitary tumors produce prolactin, but most are not considered clinically significant. Clinically significant pituitary tumors affect the health of approximately 14 out of 100,000 people in United States.